Radiopharmaceuticals company Telix Pharmaceuticals has provided its Q4 FY24 trading update, showing sustained revenue growth.

A new offering to retail investors will open the door to the kind of high-risk strategies usually reserved for clients of ...

Neuren's partner Acadia Pharmaceuticals submits marketing authorisation application in Europe for trofinetide for treatment ...

The market didn't like what this stock had to say this morning... The post Why did this $1.4 billion ASX 200 healthcare stock ...

The S&P/ASX 200 Index (ASX: XJO) surged higher this Thursday, soaring up a welcome 1.38% to finish at a flat 8,327 points.

These shares are having a tough time on hump day. But why? The post Why CAR Group, Myer, Neuren, and Yancoal shares are falling today appeared first on The Motley Fool Australia.

The Aussie sharemarket surged on Thursday, thanks to new data and led by the major banks and information technology stocks.

The Aussie market closes down despite a positive start to trade across the board, as investors look ahead for jobs data and ...

The US rally pushed the ASX to a gain of 113.7 points, or 1.4 per cent, to 8327 points at the close, with all 11 industry ...

Another ASX 200 growth share that could generate big returns according to analysts is NextDC. It is a leading provider of ...